Alspaugh Jonathan 4
4 · Aeglea BioTherapeutics, Inc. · Filed Jul 8, 2021
Insider Transaction Report
Form 4
Alspaugh Jonathan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-07-06+160,000→ 160,000 totalExercise: $7.03Exp: 2031-07-05→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/4th of the total shares on July 6, 2022, and then 1/48th of the shares will vest monthly thereafter, such that the option is fully vested on July 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.